One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

Sun Pharmaceutical Industries Ltd. 524715 shares inched down 0.79% to 1,761.80 Indian rupees Tuesday, on what proved to be an ...

The patent expiry of key drugs in 2025-26 will open up additional market space for Indian manufacturers of generics and ...

What makes these developments particularly exciting is what’s driving it. New report predicts pharmaceutical market to soar ...

Rossari Biotech slipped 4.09% to Rs 769.40 after the specialty chemical maker reported 7.82% decline in consolidated net profit to Rs 31.70 crore in Q3 FY25 as against Rs 34.39 crore posted in Q3 FY24 ...

The global biotechnology industry market size is projected to expand from USD 483.0 billion in 2024 to USD 546.0 billion by ...

当超9成biotech跌跌不休之际，2022年全球领先的20家药企市值平均增长了5.4%。这不难理解，在市场环境下行之际，充满不确定性的小药企被抛弃，抵御风险能力更强的大药企成为投资者的避风港。

While some analysts expect the 2025 IPO market to be relatively cool in the near-term, others anticipate more bids than in ...

The EBITDA margin stood at 12.6% in the reporting quarter versus 13.7% in the same period last fiscal. Shares of Rossari ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Pharmaceutical and biotech stocks may find it tough to outperform the market in the months ahead. Nonspecialist investors have shifted their focus to other sectors, such as tech, following the outcome ...

Neuren's partner Acadia Pharmaceuticals submits marketing authorisation application in Europe for trofinetide for treatment ...